Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Medtronic accepts terms of preliminary injunction

Medtronic accepts terms of preliminary injunction

30th June 2009

Medtronic has accepted the terms of an order that mean a company will not be able to use misleading marketing claims related to its Kyphon Balloon Kyphoplasty.

On May 19th, the German competition court granted the company a preliminary injunction against DFine Europe.

As part of the order, the firm is to no longer use certain promotional claims that compare its bone StabiliT ER2 to Medtronic’s KyphX HV-R Bone Cement.

DFine Europe has also agreed to the terms.

Under German law, a preliminary injunction is given as an action against anti-competitive behaviour, which includes illegal advertising.

Meanwhile, the Food and Drug administration has granted Physio-Control ? a wholly-owned subsidiary of Medtronic – marketing clearance for its next-generation Lucas Chest Compression.

The device is an automated item that gives consistent treatment to victims in cardiac arrest, without any interruptions.

President of Physio-Control Brian Webster said the product was in response to customers who had been asking for a battery-operated version of the Lucas over the last couple of years.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.